To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Clinical trial NCT01397084 · COMPLETED

Trial details

NCT number: NCT01397084
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease GERD Reflux Esophagitis

Start date: 2011-08-01
Primary completion: 2012-01-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.